parnaparin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Parnaparin is a low-molecular-weight heparin that has widely shown its efficacy and safety in prevention of venous…
SummaryAbstractParnaparin (Fluxum™) is a low molecular weight heparin (LMWH) that is effective and generally well tolerated in…
BackgroundThere are limited data on appropriate dosing of low-molecular-weight heparins (LMWHs) for venous thromboembolism (VTE…
The currently available brand-name low-molecular-weight heparins (LMWHs) in the United States include dalteparin (Pfizer…
Long-term administration of heparin can lead to development of osteoporosis. The aim of the present study was to examine the…
It is now widely accepted that various low-molecular-weight heparins (LMWHs) exhibit specific molecular and structural attributes…
AIM
Thrombin activatable fibrinolytic inhibitor (TAFI) is activated via cleavage by thrombin thrombomodulin in complex, and can…
Background: There is increasing evidence for the role of nitric oxide (NO) in haemodialysis hypotension but the source of…
Parnaparin is a low molecular weight (LMW) heparin which, like other members of its class, apparently demonstrates a greater…